MedPath

Imlastin

Brand Name: Imlastin

Generic Name: Imipenem + Cilastatin (as Sodium)

Active
Registration Number

DR-XY43649

Dosage Form

Powder For Injection (IV)

Issuance Date

August 2, 2024

Expiry Date

August 19, 2029

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength500mg/ 500mg
PackagingUSP Type I Vial x 20mL (Box of 1's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Antibacterial
A
Application
Renewal
Philippine FDA Classification

Active Ingredients (2)

Complete list of active ingredients in this pharmaceutical product.

ImipenemActive
Monograph: Imipenem
Cilastatin (as Sodium)Active
Monograph: cilastatin (as sodium)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform